Improving detection of secondary immunodeficiency and vaccination after invasive airway infections: a prospective cohort study with retrospective comparison
Internal Medicine Journal · 05.11.2026
DOI: 10.1111/imj.70690 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Internal Medicine Journal, online erschienen am 05.11.2026. Verfasst von B Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Monash Infectious Diseases, Monash Health, Melbourne, Victoria, Australia. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Infections caused by encapsulated pathogens such as Streptococcus pneumoniae , Haemophilus influenzae and Neisseria meningitidis contribute to significant morbidity and mortality, with immunodeficiency being an important risk factor for recurrent and invasive disease. A previous retrospective Australian study identified a 6% rate of newly diagnosed immunodeficiency in such patients and highlighted inadequate screening.
Methods
A prospective study at a large multi‐centre health service in South‐East Melbourne, Australia was conducted between June 2021 and September 2023. Adults (≥16 years) with the aforementioned organisms, isolated from sterile sites, were recruited. Participants underwent basic immunodeficiency testing and vaccinations. A retrospective cohort, comprising eligible but unenrolled patients over the same period, was retrospectively analysed for comparison.
Results
Patients within the prospective cohort ( n = 46) were compared with the retrospective cohort ( n = 69), with the predominant organisms being S. pneumoniae (83%, 94/115), H. influenzae (13%, 15/115) and N. meningitidis (4%, 5/115). Vaccine‐preventable strains accounted for 75% (55/73) of typed cases. A new diagnosis of immunodeficiency was identified more frequently in the prospective group (7/46, 15.2% vs 4/69, 5.8%, P = 0.1), with a numerically greater, though not statistically significant, increase in immunodeficiency detection rate seen in the prospective cohort (OR 2.9, 95% CI 0.7–14.3, P = 0.1). Post‐illness vaccinations were more frequently recommended in the prospective group (OR 2.6, 95% CI 1.0–64, P = 0.03).
Conclusion
Actively identifying patients with invasive airway pathogens and ensuring linkage with an infectious diseases service improves screening and diagnosis of immunodeficiencies and optimises vaccination opportunities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Monash Infectious Diseases, Monash Health, Melbourne, Victoria, Australia.
- School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.
- Department of Medicine and Pathology, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
- Monash Pathology, Monash Health, Melbourne, Victoria, Australia.
- Sub-Faculty of Clinical and Molecular Medicine, Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: B Tan, M Metlapalli, E L Smith, S Ojaimi
Zitieren
APA
Tan, B., Metlapalli, M., Liu, M., Kotsanas, D., Smith, E. L., & Ojaimi, S. (2026). Improving detection of secondary immunodeficiency and vaccination after invasive airway infections: a prospective cohort study with retrospective comparison. Internal Medicine Journal. https://doi.org/10.1111/imj.70690
Vancouver
Tan B, Metlapalli M, Liu M, Kotsanas D, Smith EL, Ojaimi S. Improving detection of secondary immunodeficiency and vaccination after invasive airway infections: a prospective cohort study with retrospective comparison. Internal Medicine Journal. 2026. doi:10.1111/imj.70690
BibTeX
@article{Tan2026,
author = {Tan, B and Metlapalli, M and Liu, M and Kotsanas, D and Smith, E L and Ojaimi, S},
title = {Improving detection of secondary immunodeficiency and vaccination after invasive airway infections: a prospective cohort study with retrospective comparison},
journal = {Internal Medicine Journal},
year = {2026},
doi = {10.1111/imj.70690}
}
EUVIMED